• Pharma
  • May 1, 2019
  • 110 views
Price War In Anti Diabetic Medicine Segment

A price war is brewing in India’s growing diabetes drug market, drawing comparisons with the recent tariff battles in the telecom sector. Glenmark Pharmaceuticals NSE -1.45 % has launched a patented…